Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line

Dario Caccia(Fondazione IRCCS Istituto Nazionale dei Tumori), Italia Bongarzone(Fondazione IRCCS Istituto Nazionale dei Tumori)
Molecular Cancer
October 18, 2010
Cited by 45


Related Papers